Rick G. Schwartz joined Duff & Phelps in 2005. He is a managing director in the Silicon Valley office and part of the firm’s Strategic Value Advisory practice. Rick has 30+ years of experience in providing valuation and strategic advisory services to clients in biotechnology, pharmaceuticals, healthcare, information technology, consumer products and other industries. 

Rick’s areas of expertise include valuing R&D assets, intellectual property, and early stage businesses; developing and reviewing financial projections; designing and conducting market research and market strategy analyses; performing decision analyses and real option valuations to guide business strategy; and facilitating business strategy workshops.  Rick provides litigation support and served as an expert in patent, tax, and other disputes.  

Prior to joining Duff & Phelps, Rick was a managing director at Standard & Poor’s, a director at PricewaterhouseCoopers LLP, and a principal at Applied Decision Analysis, Inc. 

Rick holds a Ph.D. in engineering-economic systems from Stanford University and a B.S. in civil engineering and B.A. in government from Cornell University. 

Schwartz /our-team/rick-schwartz /-/media/assets/images/headshots/managing-directors/rickschwartz.ashx people {B062D54C-1425-4A04-8F9F-95EA14068E6D} {E010DCD9-B7BA-4B98-9F3C-A51506B5C1D8} {51947818-C499-4911-9447-3AA383066F9E} {DF0A8D82-EB98-4261-8951-BF842E034FA8} {B871D4F9-5FCB-40B9-8710-871A30B710AB}

Related Services

Duff & Phelps Valuation Advisory Services

Valuation Advisory

Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.

Valuation Advisory
Duff & Phelps Valuation Advisory Services

Valuation Advisory

Valuation Services

Objective valuations for financial reporting, tax and management planning purposes.

Valuation Services
Duff & Phelps Valuation Advisory Services

Valuation Advisory

Business Valuation

Valuation of a business or a business interest.

Business Valuation

Case Studies

Fairness Opinion

Fairness Opinion Cogentix Medical

has converted debt into common stock and sold newly issued shares of common stock to

Fairness Opinion Cogentix Medical

Insights

News